Bionano Financial Statements From 2010 to 2026

Bionano Genomics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 136.4 M 88.2 M 84.1 M Slightly volatile Short and Long Term Debt Total 25.4 M 31.4 M 17.9 M Slightly volatile Other Current Liabilities 8.9 M 5.6 M 7.8 M Pretty Stable Total Current Liabilities 31.9 M 42.9 M 23.1 M Slightly volatile Other Liabilities 15.8 M 15.1 M 5.3 M Slightly volatile Property Plant And Equipment Net 15 M 28 M 11.2 M Slightly volatile Current Deferred Revenue 736.8 K 1.3 M 631.9 K Slightly volatile Accounts Payable 6.2 M 8 M 4.1 M Slightly volatile Cash 16.5 M 10.5 M 11.4 M Slightly volatile Non Current Assets Total 47.8 M 42.8 M 29.7 M Slightly volatile Long Term Debt 11.5 M 18.8 M 11.1 M Slightly volatile Cash And Short Term Investments 10.4 M 10.9 M 33.6 M Slightly volatile Net Receivables 5.6 M 5.5 M 4 M Slightly volatile Common Stock Total Equity 36.2 K 34.5 K 12.5 K Slightly volatile Common Stock Shares Outstanding 1.8 M 2.2 M 1.3 M Pretty Stable Long Term Debt Total 11.5 M 18.8 M 11.1 M Slightly volatile Liabilities And Stockholders Equity 136.4 M 88.2 M 84.1 M Slightly volatile Non Current Liabilities Total 3.4 M 3.6 M 21.7 M Slightly volatile Capital Surpluse 723.5 M 689.1 M 244.8 M Slightly volatile Inventory 10.7 M 12.8 M 7.2 M Slightly volatile Other Current Assets 8.8 M 16.2 M 6 M Slightly volatile Total Liabilities 52.1 M 47.5 M 45.8 M Slightly volatile Property Plant And Equipment Gross 61.8 M 58.9 M 17.8 M Slightly volatile Short and Long Term Debt 84.3 M 80.3 M 33.2 M Slightly volatile Preferred Stock Total Equity 37.6 M 49.5 M 35.8 M Slightly volatile Total Current Assets 88.6 M 45.4 M 54.3 M Slightly volatile Non Current Liabilities Other 8.4 M 12.5 M 6.4 M Slightly volatile Short Term Debt 20.3 M 27.2 M 12.9 M Slightly volatile Common Stock 8.3 K 5.8 K 4.7 K Slightly volatile Property Plant Equipment 21.8 M 20.7 M 8.6 M Slightly volatile Deferred Long Term Liabilities 137.3 K 114.3 K 223.5 K Slightly volatile Other Assets 1.7 K 1.8 K 111 K Very volatile Intangible Assets 10.6 M 11.2 M 8.8 M Slightly volatile
Bionano Genomics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 17.2 M 16.4 M 5.2 M Slightly volatile Interest Expense 315.7 K 332.4 K 1 M Pretty Stable Selling General Administrative 47 M 59.6 M 33.5 M Slightly volatile Total Revenue 19.5 M 35.4 M 15 M Slightly volatile Gross Profit 415.1 K 437 K 3.3 M Very volatile Other Operating Expenses 99.8 M 155 M 72.9 M Slightly volatile Research Development 24.8 M 28.5 M 19.1 M Slightly volatile Cost Of Revenue 36.7 M 35 M 12.8 M Slightly volatile Total Operating Expenses 84.6 M 120 M 61.4 M Slightly volatile Reconciled Depreciation 17.2 M 16.4 M 5.3 M Slightly volatile
Bionano Genomics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 7.6 M 11.2 M 4.8 M Slightly volatile Begin Period Cash Flow 16.1 M 21.1 M 11.6 M Slightly volatile Depreciation 17.2 M 16.4 M 5.2 M Slightly volatile Other Non Cash Items 14.1 M 16.9 M 8.6 M Slightly volatile Capital Expenditures 112.5 K 118.5 K 1.3 M Pretty Stable End Period Cash Flow 16.7 M 11 M 11.5 M Slightly volatile Issuance Of Capital Stock 85.9 M 51.1 M 49.4 M Slightly volatile Dividends Paid 1.6 M 1.8 M 2 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 1.17 1.23 6.2794 Slightly volatile PTB Ratio 1.02 1.07 1.054 Slightly volatile Days Sales Outstanding 61.86 65.11 106 Pretty Stable Book Value Per Share 20.31 21.38 27.4 K Slightly volatile Average Payables 1.9 M 2.5 M 2.3 M Slightly volatile Stock Based Compensation To Revenue 0.23 0.28 0.1878 Slightly volatile Capex To Depreciation 0.0079 0.0083 0.6355 Slightly volatile PB Ratio 1.02 1.07 1.054 Slightly volatile Inventory Turnover 2.83 3.14 2.4165 Very volatile Days Of Inventory On Hand 177 120 199 Pretty Stable Payables Turnover 3.42 5.02 3.7388 Slightly volatile Sales General And Administrative To Revenue 1.67 1.36 1.5383 Slightly volatile Average Inventory 1.7 M 3 M 2.4 M Slightly volatile Research And Ddevelopement To Revenue 1.36 0.93 1.3849 Slightly volatile Capex To Revenue 0.0037 0.0038 0.11 Slightly volatile Cash Per Share 5.44 5.73 46.1 K Slightly volatile Days Payables Outstanding 118 75.24 118 Slightly volatile Income Quality 1.0 0.71 1.0245 Slightly volatile Intangibles To Total Assets 0.23 0.15 0.1673 Slightly volatile Current Ratio 0.9 0.95 2.4125 Pretty Stable Tangible Book Value Per Share 14.74 15.51 27.3 K Slightly volatile Receivables Turnover 6.09 5.8 3.8277 Slightly volatile Shareholders Equity Per Share 20.31 21.38 27.4 K Slightly volatile Capex Per Share 0.0591 0.0623 885 Slightly volatile Average Receivables 3 M 4.1 M 3.5 M Slightly volatile Revenue Per Share 17.67 18.6 33.1 K Slightly volatile Interest Debt Per Share 15.84 16.67 30.6 K Slightly volatile Debt To Assets 0.4 0.41 0.3944 Slightly volatile Operating Cycle 273 171 306 Pretty Stable Price Book Value Ratio 1.02 1.07 1.054 Slightly volatile Days Of Payables Outstanding 118 75.24 118 Slightly volatile Ebt Per Ebit 0.82 0.97 0.9594 Slightly volatile Quick Ratio 0.65 0.68 2.1404 Pretty Stable Net Income Per E B T 1.09 1.15 1.0112 Slightly volatile Cash Ratio 0.27 0.28 0.8727 Very volatile Cash Conversion Cycle 155 95.9 188 Pretty Stable Days Of Inventory Outstanding 177 120 199 Pretty Stable Days Of Sales Outstanding 61.86 65.11 106 Pretty Stable Free Cash Flow Operating Cash Flow Ratio 1.12 1.15 1.0483 Very volatile Price To Book Ratio 1.02 1.07 1.054 Slightly volatile Fixed Asset Turnover 2.77 1.46 2.1766 Very volatile Debt Ratio 0.4 0.41 0.3944 Slightly volatile Price Sales Ratio 1.17 1.23 6.2794 Slightly volatile Asset Turnover 0.37 0.46 0.3912 Slightly volatile Gross Profit Margin 0.0135 0.0142 0.3143 Slightly volatile Price Fair Value 1.02 1.07 1.054 Slightly volatile
Bionano Genomics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 28.1 M 29.6 M 101.9 M Slightly volatile

Bionano Fundamental Market Drivers

Bionano Upcoming Events

About Bionano Genomics Financial Statements

Pair Trading with Bionano Genomics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionano Genomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will appreciate offsetting losses from the drop in the long position's value.When determining whether Bionano Genomics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bionano Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bionano Genomics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bionano Genomics Stock:

How To Invest In Bionano Details

Is Bionano Stock a good investment? Details

What is Bionano Genomics' Net Worth? Details

Largest Life Sciences Tools & Services Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details